Shorts On Watch: Core Laboratories NV (NYSE:CLB) Shorted Shares Decreased By 0.62%

November 29, 2016 - By Ellis Scott   ·   0 Comments

Shorts On Watch: Core Laboratories NV (NYSE:CLB) Shorted Shares Decreased By 0.62%

The stock of Core Laboratories NV (NYSE:CLB) registered a decrease of 0.62% in short interest. CLB’s total short interest was 6.18M shares in November as published by FINRA. Its down 0.62% from 6.22M shares, reported previously. With 663,200 shares average volume, it will take short sellers 9 days to cover their CLB’s short positions. The short interest to Core Laboratories NV’s float is 14.29%. About 186,913 shares traded hands. Core Laboratories N.V. (NYSE:CLB) has declined 17.74% since April 26, 2016 and is downtrending. It has underperformed by 23.00% the S&P500.

Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the gas and oil industry. The company has a market cap of $4.59 billion. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase gas and oil recovery from their producing fields. It has a 71.52 P/E ratio. The Firm has over 70 offices in over 50 countries.

Insitutional Activity: The institutional sentiment increased to 1.13 in 2016 Q2. Its up 0.04, from 1.09 in 2016Q1. The ratio improved, as 37 funds sold all Core Laboratories N.V. shares owned while 118 reduced positions. 53 funds bought stakes while 116 increased positions. They now own 43.11 million shares or 0.25% more from 43.00 million shares in 2016Q1.
Barclays Public Ltd Co holds 0% or 27,696 shares in its portfolio. Columbia Wanger Asset Mngmt has 0.19% invested in the company for 131,706 shares. Gsa Capital Prns Limited Liability Partnership holds 0.02% or 2,994 shares in its portfolio. The North Carolina-based Kingfisher Cap Lc has invested 0% in Core Laboratories N.V. (NYSE:CLB). Underhill Investment Mngmt Ltd Liability has invested 6.17% of its portfolio in Core Laboratories N.V. (NYSE:CLB). Macquarie Limited last reported 763,166 shares in the company. Jackson Square Prtnrs Lc accumulated 1.42M shares or 0.98% of the stock. Teachers Advsrs last reported 35 shares in the company. The Japan-based Mizuho Trust & Banking Ltd has invested 0.02% in Core Laboratories N.V. (NYSE:CLB). Goldman Sachs Gru Inc accumulated 0% or 81,543 shares. Sheffield Asset Mngmt Ltd Liability has 5.07% invested in the company for 137,410 shares. Jlb And Assoc last reported 16,873 shares in the company. Mizuho Asset Mngmt Coltd accumulated 521 shares or 0.01% of the stock. Gofen And Glossberg Ltd Liability Il last reported 0.07% of its portfolio in the stock. Bradley Foster & Sargent Ct holds 10,080 shares or 0.06% of its portfolio.

Core Laboratories N.V. (NYSE:CLB) Ratings Coverage

Out of 15 analysts covering Core Laboratories (NYSE:CLB), 8 rate it a “Buy”, 0 “Sell”, while 7 “Hold”. This means 53% are positive. Core Laboratories has been the topic of 27 analyst reports since August 24, 2015 according to StockzIntelligence Inc. Citigroup maintained the stock with “Neutral” rating in Monday, May 16 report. The rating was initiated by DA Davidson on Thursday, October 6 with “Buy”. The stock of Core Laboratories N.V. (NYSE:CLB) has “Market Perform” rating given on Monday, October 26 by Cowen & Co. The rating was upgraded by Guggenheim to “Buy” on Monday, November 30. Howard Weil maintained Core Laboratories N.V. (NYSE:CLB) rating on Friday, January 29. Howard Weil has “Sector Perform” rating and $105 price target. On Tuesday, January 12 the stock rating was initiated by Oppenheimer with “Perform”. The firm has “Overweight” rating by JP Morgan given on Friday, June 10. On Tuesday, April 19 the stock rating was maintained by Morgan Stanley with “Overweight”. Sterne Agee CRT maintained the stock with “Neutral” rating in Wednesday, September 30 report. KLR Group initiated the stock with “Buy” rating in Monday, December 14 report.

CLB Company Profile

Core Laboratories N.V., incorporated on July 8, 1994, is a well-known provider of reservoir description, production enhancement and reservoir management services to the gas and oil industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase gas and oil recovery from their producing fields. The Firm has over 70 offices in over 50 countries. The Firm operates in three divisions: Reservoir Description, Production Enhancement and Reservoir Management. These divisions provide different services and products and utilize different technologies for improving reservoir performance, and increasing gas and oil recovery from new and existing fields. The Firm offers its services through its global network of offices. The Firm makes products primarily in over four facilities for distribution on a global basis.

More notable recent Core Laboratories N.V. (NYSE:CLB) news were published by: Fool.com which released: “Core Laboratories NV’s Earnings Sparked a 13% Slide in October, Should …” on November 08, 2016, also Fool.com with their article: “Core Laboratories NV Earnings Bottom Out” published on July 21, 2016, Fool.com published: “What’s Core Laboratories N.V. Doing to Outperform Its Oil-Service Peers?” on November 08, 2015. More interesting news about Core Laboratories N.V. (NYSE:CLB) were released by: Seekingalpha.com and their article: “Core Laboratories NV (CLB) CEO David Demshur on Q3 2016 Results – Earnings …” published on October 20, 2016 as well as Prnewswire.com‘s news article titled: “Core Lab Reports Q3 2016 Results:” with publication date: October 19, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Ellis Scott

Tags: , ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>